drugset / Trial / NCT05345964
Phase I Study of GST-HG151 Tablets in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindOther
Summary
To Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Impact of GST-HG151 Tablets in Single-dose and Multiple-dose in Healthy Volunteers
Timeline
- Start
- 2022-03-07
- Primary completion
- 2023-03-31
- Completion
- 2023-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | GST-HG151 | Unknown | 5 mg | Oral |
| Comparator | GST-HG151 | Unknown | 15 mg | Oral |
| Comparator | GST-HG151 | Unknown | 30 mg | Oral |
| Comparator | GST-HG151 | Unknown | 60 mg | Oral |
| Comparator | GST-HG151 | Unknown | 90 mg | Oral |
| Comparator | GST-HG151 | Unknown | 120 mg | Oral |
| Comparator | GST-HG151 | Unknown | 150 mg | Oral |
| Comparator | GST-HG151 | Unknown | 180 mg | Oral |
Indications
No indication recorded.